<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" > <channel><title>Comments on: Implications of the Arcoxia rejection</title> <atom:link href="http://www.kevinmd.com/blog/2007/04/implications-of-arcoxia-rejection.html/feed" rel="self" type="application/rss+xml" /><link>http://www.kevinmd.com/blog/2007/04/implications-of-arcoxia-rejection.html</link> <description></description> <lastBuildDate>Tue, 14 Feb 2012 22:04:00 +0000</lastBuildDate> <sy:updatePeriod>hourly</sy:updatePeriod> <sy:updateFrequency>1</sy:updateFrequency> <xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /> <item><title>By: Anonymous</title><link>http://www.kevinmd.com/blog/2007/04/implications-of-arcoxia-rejection.html#comment-73998</link> <dc:creator>Anonymous</dc:creator> <pubDate>Tue, 17 Apr 2007 19:33:00 +0000</pubDate> <guid isPermaLink="false">http://clients.emmense.com/kevinmd/2007/04/implications-of-the-arcoxia-rejection.html#comment-73998</guid> <description>Kevin:  &lt;br/&gt;&lt;br/&gt;Do you know that this drug is safe?  Do you know what they compared it to?  Do you know how weak that data set they brought to the table was? Do you think comparing a drug in a class known for increased cardio risk with a drug with increased cardio risk would make an analytically persuasive case for safety (rather than naproxen: equally as effective; 3x less cardio risk)?&lt;br/&gt;Did you see who was actually on that panel, and did you happen to know that there were are large number of physicians who espouse the very same views on having options for their patients?  Do you know who Scott Gottlieb is?  Do you care about intellectual honesty as much as the good Mr. Gottlieb?</description> <content:encoded><![CDATA[<p>Kevin:</p><p>Do you know that this drug is safe?  Do you know what they compared it to?  Do you know how weak that data set they brought to the table was? Do you think comparing a drug in a class known for increased cardio risk with a drug with increased cardio risk would make an analytically persuasive case for safety (rather than naproxen: equally as effective; 3x less cardio risk)?<br />Did you see who was actually on that panel, and did you happen to know that there were are large number of physicians who espouse the very same views on having options for their patients?  Do you know who Scott Gottlieb is?  Do you care about intellectual honesty as much as the good Mr. Gottlieb?</p> ]]></content:encoded> </item> </channel> </rss>
<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using apc
Page Caching using disk: enhanced
Database Caching 2/6 queries in 0.003 seconds using memcached
Object Caching 341/345 objects using apc
Content Delivery Network via cdn.kevinmd.com

Served from: www.kevinmd.com @ 2012-02-14 17:42:50 -->
